Drug-Resistant Infections & the Immediate and Future Demand for Novel Antimicrobials

Congressional policymakers, federal policymakers, their advisors, and stakeholders interested in addressing drug-resistant infections and antimicrobial resistance (AMR) are invited to learn about the clinical and public health impact of drug-resistant infections and why policymakers are proposing new incentives for novel antimicrobials. Expert speakers will highlight:

The current and future threat of drug-resistant infections and antimicrobial resistance
Market uncertainties that complicate antimicrobial development and commercialization
Existing and proposed incentives for novel antimicrobials, including the PASTEUR Act

[juliaschaletzkyphd]

Thanks Mark & team for discussing this very important topic!